Attendo AB (publ) (ATT.ST)

Attendo AB (publ) (ATT.ST) — VMCI valuation read

Attendo AB (publ) sits at VMCI 57/100, with the Healthcare sector median at 50. That 7-point spread is the first thing to note on ATT.ST: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on ATT.ST are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on ATT.ST: ATT.ST trades at 18.0x earnings, 0% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of -1.7x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

ATT.ST fell 3.7% over the trailing 7 days, with a -3.3% read on a 30-day basis.